Neola Medical
Neola Medical to Participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco
Neola Medical AB (publ) is pleased to announce its participation in the 43rd Annual J.P. Morgan Healthcare Conference, set to take place January 13–16, 2025, in San Francisco, California. The event, recognized as the premier global healthcare investment symposium, provides an unparalleled platform for connecting with industry leaders, innovative companies, and investors shaping the future of Life Sciences.
CEO Hanna Sjöström will attend to engage with investors and potential industry partners, focusing on the company’s preparations for the anticipated U.S. market launch of Neola®, its advanced continuous lung monitoring device designed to improve care for preterm born babies in neonatal intensive care units.
"The J.P. Morgan Healthcare Conference offers an invaluable opportunity to strengthen Neola Medical’s position as we advance toward commercialization. This event allows us to showcase our progress, forge meaningful partnerships, and align with key stakeholders who are essential to our U.S. market entry and scaling efforts.” says Hanna Sjöström, CEO of Neola Medical.
As Neola Medical prepares for FDA approval, the company is actively laying the foundation for successful commercialization in the U.S. This includes strategic efforts to demonstrate the technology’s value in clinical settings, build a strong sales presence, and establish effective market entry channels to support future growth.
For more information about the J.P. Morgan Healthcare Conference: https://www.jpmorgan.com/solutions/cib/insights/health-care-conference
| Datum | 2025-01-09, kl 07:00 |
| Källa | MFN |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.